Press release
Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving Market Acceleration in the Gastric Cancer Drugs Industry, 2025
Gastric Cancer Drugs Market Size
How Large Will the Gastric Cancer Drugs Market Size By 2025?
In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing to this period's growth include risen expenditure in pharmaceutical research and development, heightened healthcare spending, substantial financial growth in emerging markets, as well as a rapid rise in the elderly population.
How Big Is the Gastric Cancer Drugs Market Size Expected to Grow by 2029?
In the coming years, the market size for drugs used in gastric cancer treatments is projected to experience exponential growth. The value of this market is forecasted to reach $7.35 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%. Several factors such as increasing incidence rates of gastric cancer, a robust pipeline of medications, a rise in company acquisitions and partnerships, an increase in healthcare spending, a growing elderly population, and modifications in FDA regulations promoting biologics drug development will contribute to this predicted growth. Key trends in this outlook period encompass strategic collaborations and agreements aimed at expanding product ranges, teaming up with other corporations or government entities, prioritizing the increase in the number of studies to improve gastric cancer drug development, investment in artificial intelligence for lowering R&D expenses, the production of next-generation biologics, and the application of CRISPR-cas9 technology in the creation of new drugs.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Which Key Market Drivers Powering Gastric Cancer Drugs Market Expansion and Growth?
The rise in gastric cancer cases is attributable to the growing obesity and smoking rates. Unhealthy dietary habits and tobacco consumption are major risk factors for stomach cancer. It is worth noting that statistics from the Government Digital Service in the United Kingdom revealed that the obesity rate for adults (18 and older) in England shot up from 25.2% to 25.9% between 2022 and 2023. Consequently, this spike in gastric cancer instances will contribute to the expansion of the gastric cancer drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2603&type=smp
Which Emerging Trends Are Transforming the Gastric Cancer Drugs Market in 2025?
A number of businesses in the gastric cancer drugs market are developing cutting-edge products, like anti-PD-1 therapies, to maximize the effectiveness of treatment and enhance patient prognosis. Anti-PD-1 therapy is an immunotherapy form that focuses on the programmed cell death protein 1 (PD-1) receptor of immune cells. For instance, in November 2023, Merck & Co., Inc., an American pharmaceutical company, got the green light from the Food and Drug Administration (FDA), an agency in the US tasked with protecting public health, for KEYTRUDA (pembrolizumab). KEYTRUDA (pembrolizumab) is an anti-PD-1 therapy employed for the treatment of gastric cancer. Specifically, KEYTRUDA is recommended for the initial treatment of patients suffering from either locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma, intended for use together with trastuzumab, fluoropyrimidine- and platinum-based chemotherapy. This indication received swift approval based on the rate of tumor response and the enduring nature of that response.
What Are the Emerging Segments in the Gastric Cancer Drugs Market?
The gastric cancer drugs market covered in this report is segmented -
1) By Type: Imatinib, Trastuzumab, Other Types
2) By Route of Administration: Oral, Parenteral
3) By End User: Hospitals, Clinics, Cancer Speciality Centers
Subsegments:
1) By Imatinib: Oral Formulations, Injectable Formulations, Combination Therapies
2) By Trastuzumab: Monotherapy, Combination Therapy With Chemotherapy, Biosimilars Of Trastuzumab
3) By Other Types: Chemotherapy Agents, Targeted Therapy Agents, Immunotherapy Agents, Supportive Care Medications
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2603&type=smp
Who Are the Global Leaders in the Gastric Cancer Drugs Market?
Major companies operating in the gastric cancer drugs market include F. Hoffmann-La Roche, Eli Lilly and Company, Otsuka Pharmaceutical, Jiangsu HengRui Medicine, Biocon, Sanofi, PV Pharma Healthcare (India), Roche India, Novartis Oncology, Arlak Biotech (India), Healthkind labs Pvt. Ltd., SwisscheM Healthcare Pvt.Ltd, Apikos Pharma, Kolaz biotech., CStone Pharma (China), CARsgen Therapeutics (China), JW Therapeutics (China), BeiGene(China), Takeda Pharmaceuticals (Japan), Astellas Pharma Inc (Japan), Daiichi Pharmaceutical and Sankyo (Japan), AQVIDA GmbH, AstraZeneca plc, GlaxoSmithKline plc, Veropharm, Biocad, Bristol-Myers Squibb, Celon Pharma, Celltrion Inc., Imugene Limited, Merck & Co. Inc., Pfizer Inc., Sandoz AG (A Novartis Division), Eurofarma Laboratórios S.A., TUTEUR ArgentinaPierre Fabre Group, Celnova Pharma, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Gulf Pharmaceutical Industries (Julphar), Abbott Laboratories, Mylan Laboratories, Gilead Sciences, BMS, Ascedis Health
Which are the Top Profitable Regional Markets for the Gastric Cancer Drugs Industry?
North America was the largest region in the gastric cancer drugs market in 2024. Middle East is expected to be the largest growing region in the global gastric cancer drugs market share during the forecast period. The regions covered in the gastric cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2603
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving Market Acceleration in the Gastric Cancer Drugs Industry, 2025 here
News-ID: 4182177 • Views: …
More Releases from The Business Research Company
HP (High Potency) APIs Market Expected to Achieve 9.4% CAGR by 2029: Growth Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the HP (High Potency) APIs Market Size By 2025?
The market size of high potency APIs (HP-APIs) has seen robust growth in the past few years. In terms of projections, it is expected to expand from $25.2 billion in 2024 to $27.2 billion in 2025, demonstrating…
Nutritional Supplement Market Growth Fueled By Rising Non-Communicable Diseases: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nutritional Supplements Industry Market Size Be by 2025?
The market for nutritional supplements has seen notable expansion in the past. There will be an increase from $414.85 billion in 2024 to $440.77 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. Factors such…
Enzyme Market Surges With The Growing Prevalence Of Digestive Disorders: Pivotal …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Enzymes Market Size Growth Forecast: What to Expect by 2025?
In recent times, the enzymes market has witnessed a swift growth. Its size is expected to escalate from $13.38 billion in 2024 to $15.2 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.6%. Factors contributing to…
2025-2034 Medical Marijuana Market Outlook: Key Drivers, Emerging Challenges, an …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Medical Marijuana Industry Market Size Be by 2025?
The market size for medical marijuana has seen a speedy expansion in the past few years. The market is projected to rise from a value of $32.96 billion in 2024 to about $39.52 billion in 2025, posting a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
